Celecoxib API Market
Celecoxib API Market Size and Growth
The Celecoxib API market shows robust growth, driven by rising demand for anti-inflammatory medications. The current market size is estimated to reach USD 1.2 billion by 2025, with a projected CAGR of 5.2%. Increasing incidence of arthritis and related disorders fuels market expansion amid evolving regulatory landscapes and competitive dynamics.
Companies Covered
(Covid 19 Impact Covered)
◍ Pfizer
◍ Teva Pharmaceuticals
◍ Viatris(Mylan)
◍ ScinoPharm
◍ Jiangxi Synergy
◍ Jiangsu Hengrui Medicine
◍ Jiangsu Chiatai Qingjiang
◍ Hisun Pharmaceutical Nantong
◍ Aurobindo Pharma
◍ Punjab Chemicals
The Celecoxib API market features key players like Pfizer, Teva, and Aurobindo, focusing on production and innovation to enhance market reach. Companies leverage partnerships, optimize manufacturing, and expand markets, driving growth. Financial highlights include Pfizer with $81.3 billion (2022) and Teva with $15.3 billion (2021) in sales revenue. Request Sample Report
Market Segmentation
By Application
Pharmaceutical
Laboratory
Request Sample Report
By Product
Standard grade Celecoxib API
Micronized Celecoxib API
Market Growth
Request Sample Report
$ X Billion USD
